Acuta Capital Partners, LLC Chembio Diagnostics, Inc. Transaction History

Acuta Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.94 - $5.76 $164,167 - $240,001	-41,667 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$5.32 - $7.18 $1.84 Million - $2.48 Million	-345,500 Reduced 89.24%	41,667 $231,000
Q4 2018 Feb 14, 2019	SELL	$4.95 - $10.5 $8.13 Million - $17.3 Million	-1,643,366 Reduced 80.93%	387,167 $2.19 Million
Q2 2018 Aug 15, 2018	BUY	$7.8 - $11.1 $186,154 - $264,912	23,866 Added 1.19%	2,030,533 $22.5 Million
Q1 2018 May 15, 2018	BUY	$7.05 - $9.0 $2.01 Million - $2.57 Million	285,368 Added 16.58%	2,006,667 $16.1 Million
Q3 2017 Nov 14, 2017	BUY	$5.85 - $6.2 $10.1 Million - $10.7 Million	1,721,299	1,721,299 $10.7 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.